Your browser doesn't support javascript.
loading
Potentially actionable pharmacogenetic variants and symptom control medications in oncology.
Patel, Jai N; Boselli, Danielle; Jandrisevits, Elizabeth J; Hamadeh, Issam S; Salem, Ahmed; Meadors, Patrick; Walsh, Declan.
  • Patel JN; Department of Cancer Pharmacology & Pharmacogenomics, Atrium Health Levine Cancer Institute, 1021 Morehead Medical Drive, Charlotte, NC, 28204, USA. jai.patel@atriumhealth.org.
  • Boselli D; Department of Biostatistics, Atrium Health Levine Cancer Institute, Charlotte, NC, USA.
  • Jandrisevits EJ; Department of Cancer Pharmacology & Pharmacogenomics, Atrium Health Levine Cancer Institute, 1021 Morehead Medical Drive, Charlotte, NC, 28204, USA.
  • Hamadeh IS; Department of Cancer Pharmacology & Pharmacogenomics, Atrium Health Levine Cancer Institute, 1021 Morehead Medical Drive, Charlotte, NC, 28204, USA.
  • Salem A; Department of Cancer Pharmacology & Pharmacogenomics, Atrium Health Levine Cancer Institute, 1021 Morehead Medical Drive, Charlotte, NC, 28204, USA.
  • Meadors P; Section of Psycho-oncology, Center for Supportive Care and Survivorship, Atrium Health Levine Cancer Institute, Charlotte, NC, USA.
  • Walsh D; Department of Supportive Oncology, Atrium Health Levine Cancer Institute, Charlotte, NC, USA.
Support Care Cancer ; 29(10): 5927-5934, 2021 Oct.
Article en En | MEDLINE | ID: mdl-33758969

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pruebas de Farmacogenómica / Variantes Farmacogenómicas Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pruebas de Farmacogenómica / Variantes Farmacogenómicas Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Año: 2021 Tipo del documento: Article